Four Sample Of Piecan Pharma Fail In Quality Tests

Jaipur: Four samples of cefixime antibiotics, produced by the same pharma company that was raided by FDCA in Gujarat, have failed the quality test in Rajasthan.

The seized samples of the antibiotic had no cefixime in them. Piecan Pharma, the drug manufacturer, was raided by FDCA in Gujarat during a crackdown on spurious drugs. The same drugs, also being sold in Rajasthan, were seized by FDCA and Rs 6 lakh worth of the spurious antibiotic was recovered. The state team has informed its Gujarat counterparts.

“The cefixime tablets manufactured by Piecan Pharma failed quality test. We found that it did not contain cefixime content in it,” said Ajay Phatak, drug controller (I), health department. Phatak said, “Spurious drugs racket was busted in Gujarat where action against Piecan Pharma was taken.”

The state’s FSDC also conducted searches. “We found these drugs stored at 13 places. We have seized the stock of these drugs which costs around Rs 6-lakh,” said Phatak.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre